Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis
Federica Tavaglione, Rohit Loomba · 2026
Read Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis by Federica Tavaglione, Rohit Loomba (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13589479.txt.
Description
Federica Tavaglione and Rohit Loomba review a fast-growing drug family for a serious liver disease called MASH. Their review appeared in twenty twenty-six. In MASH, fat and scarring build up in the liver, and the first approved drugs have only just arrived.
The drugs covered here copy a gut hormone called GLP-1, alone or paired with one or two partner hormones. They act on sugar and fat handling across many organs, and they also help the heart and kidneys. The review walks through how each type works and what phase two and phase three trials found on liver scarring. Open questions remain about how long treatment should last, how well patients tolerate the drugs, and why responses vary.
Catalog record
| CREATOR | Federica Tavaglione, Rohit Loomba |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |